- Home
- BSM vs HTFL Comparison
BSM vs HTFL Comparison
Compare BSM & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSM
- HTFL
- Stock Information
- Founded
- BSM 1876
- HTFL 2007
- Country
- BSM United States
- HTFL United States
- Employees
- BSM N/A
- HTFL N/A
- Industry
- BSM Oil & Gas Production
- HTFL
- Sector
- BSM Energy
- HTFL
- Exchange
- BSM Nasdaq
- HTFL Nasdaq
- Market Cap
- BSM 2.5B
- HTFL 2.8B
- IPO Year
- BSM 2015
- HTFL 2025
- Fundamental
- Price
- BSM $13.31
- HTFL $32.56
- Analyst Decision
- BSM Hold
- HTFL Strong Buy
- Analyst Count
- BSM 1
- HTFL 4
- Target Price
- BSM $13.00
- HTFL $37.00
- AVG Volume (30 Days)
- BSM 462.8K
- HTFL 242.8K
- Earning Date
- BSM 11-03-2025
- HTFL 11-12-2025
- Dividend Yield
- BSM 9.02%
- HTFL N/A
- EPS Growth
- BSM N/A
- HTFL N/A
- EPS
- BSM 1.16
- HTFL N/A
- Revenue
- BSM $412,814,000.00
- HTFL $148,540,000.00
- Revenue This Year
- BSM $1.60
- HTFL $34.51
- Revenue Next Year
- BSM $10.48
- HTFL $24.58
- P/E Ratio
- BSM $11.50
- HTFL N/A
- Revenue Growth
- BSM N/A
- HTFL 44.32
- 52 Week Low
- BSM $11.78
- HTFL $26.56
- 52 Week High
- BSM $15.66
- HTFL $41.22
- Technical
- Relative Strength Index (RSI)
- BSM 57.76
- HTFL N/A
- Support Level
- BSM $12.93
- HTFL N/A
- Resistance Level
- BSM $13.44
- HTFL N/A
- Average True Range (ATR)
- BSM 0.21
- HTFL 0.00
- MACD
- BSM 0.03
- HTFL 0.00
- Stochastic Oscillator
- BSM 82.39
- HTFL 0.00
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.
About HTFL Heartflow Inc. Common Stock
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.